Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 36894001000001114 | Sorafenib tosylate (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 36894101000001110 | Sorafenib tosylate | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Sorafenib tosylate | Is a | Sorafenib | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Nexavar 200mg tablets (Bayer Plc) | Has active ingredient | False | Sorafenib tosylate | Inferred relationship | Existential restriction modifier | |
| Sorafenib 200mg tablets 112 tablet | Has active ingredient | False | Sorafenib tosylate | Inferred relationship | Existential restriction modifier | |
| Nexavar 200mg tablets (Bayer Plc) 112 tablet 4 x 28 tablets | Has active ingredient | False | Sorafenib tosylate | Inferred relationship | Existential restriction modifier | |
| Product containing precisely sorafenib (as sorafenib tosylate) 200 milligram/1 each conventional release oral tablet | Has active ingredient | False | Sorafenib tosylate | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR